ADC – Socially Bharat

socially bharat
January 10, 2025
3 Mins Read

Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment

Beijing, China & Prague, Czech Republic: Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody

128 Views
0 Comments

READ MORE

socially bharat
December 16, 2024
2 Mins Read

Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development

Beijing, China: Adcendo exercises its option to utilize Biocytogen’s fully human antibodies to further expand its ADC pipeline for

102 Views
0 Comments

READ MORE

socially bharat
November 11, 2024
3 Mins Read

Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise

Beijing, China & South San Francisco, Calif., United States: IDEAYA has exercised the option for an exclusive worldwide license

120 Views
0 Comments

READ MORE

Socially Bharat is your comprehensive source for Social news, NGO’s, and expert insights from across India.

Quick Links

Contact Us

Stay Updated

Share Your Message!

Copyright© 2025 Creative Bharat Powered By A Buzz Company